mRNA as novel technology for passive immunotherapy

While active immunization elicits a lasting immune response by the body, passive immunotherapy transiently equips the body with exogenously generated immunological effectors in the form of either target-specific antibodies or lymphocytes functionalized with target-specific receptors. In either case,...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlake, Thomas, Thess, Andreas, Thran, Moritz, Jordan, Ingo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339677/
https://www.ncbi.nlm.nih.gov/pubmed/30334070
http://dx.doi.org/10.1007/s00018-018-2935-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339677/
https://www.ncbi.nlm.nih.gov/pubmed/30334070
http://dx.doi.org/10.1007/s00018-018-2935-4

Ejemplares similares